MSD ANIMAL HEALTH UK LIMITED
Get an alert when MSD ANIMAL HEALTH UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-27 (this month)
Last made up 2025-05-13
Watchouts
None on the register
Cash
£4K
Latest balance sheet
Net assets
£159M
-4.4% vs 2023
Employees
252
-2.7% vs 2023
Profit before tax
£8M
+3.6% vs 2023
Name history
Renamed 2 times since incorporation
- MSD ANIMAL HEALTH UK LIMITED 2020-03-27 → present
- INTERVET UK LIMITED 1987-04-15 → 2020-03-27
- INTERVET LABORATORIES LIMITED 1969-01-29 → 1987-04-15
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £185,890,000 | £198,456,000 | |
| Operating profit | £3,944,000 | £4,798,000 | |
| Profit before tax | £7,330,000 | £7,596,000 | |
| Net profit | £3,459,000 | £4,410,000 | |
| Cash | — | £4,000 | |
| Total assets less current liabilities | £183,209,000 | £177,848,000 | |
| Net assets | £166,795,000 | £159,459,000 | |
| Equity | £166,795,000 | £159,459,000 | |
| Average employees | 259 | 252 | |
| Wages | £17,194,000 | £17,823,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 2.1% | 2.4% | |
| Net margin | 1.9% | 2.2% | |
| Return on capital employed | 2.2% | 2.7% | |
| Current ratio | 1.44x | 1.28x | |
| Interest cover | 4.95x | 7.69x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Given the matters described above, the Directors believe that the Company has the resources required to settle all liabilities via the group cash pooling arrangement as they fall due for at least 12 months from the date of signing the financial statements and that no material uncertainties exist. Accordingly, the financial statements have been prepared on a going concern basis. The directors remain confident on the basis of the future projections that they have adequate resources to continue in operation for the foreseeable future.”
Group structure
- MSD ANIMAL HEALTH UK LIMITED · parent
- Intervet UK Production Limited 100%
- MSD Pensions Trustee Limited 100%
Significant events
- “On 1 October 2024, the company acquired the trade and net assets of the IdentiGEN UK branch business from IdentiGEN Limited, a company registered in Ireland. Both MSD Animal Health UK Ltd and IdentiGEN Ltd have the same ultimate parent company.”
- “On 8 March 2013, Merck KGaA, Darmstadt, Germany (KGaA) commenced legal proceedings in the UK... That claim was heard in July 2025, and a judgement made awarding damages to the plaintiff. The ultimate parent company... will settle these damages. Accordingly, no provision has been recorded at 31 December 2024...”
- “In June 2023, the High Court handed down a decision (Virgin Media Limited v NTL Pension Trustees II Limited and others) that amendments to scheme rules were invalid... In June 2025, the UK Government announced they will be introducing legislation...”
- “The directors have approved the payment of an interim dividend in respect of 2025, for the value of £10,000,000, to be paid on 26 November 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 28 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CAN TEMUCIN, Ebru | Director | 2018-07-05 | Oct 1972 | Turkish |
| CASAGRANDE, Henrique Augusto | Director | 2026-01-31 | Mar 1977 | Brazilian,American |
| LITVIN, Dionna Kathleen | Director | 2023-10-31 | Aug 1970 | American |
Show 28 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOUW, Andreas Johannes Louis Maria | Secretary | 2005-04-18 | 2007-03-16 |
| BURWOOD, Alan Edward | Secretary | — | 2005-04-18 |
| PLAYFORD, Richard | Secretary | 2007-03-16 | 2008-12-05 |
| VAN HEUMEN, Marcus | Secretary | 2008-12-05 | 2013-01-31 |
| BATTISON, John Robert | Director | 1995-07-03 | 2002-04-01 |
| BAXENDALE, William | Director | — | 2004-03-31 |
| BOLCSKEI, Andras | Director | 2012-09-25 | 2015-10-01 |
| CASADY, Paul Stoughton | Director | 2002-04-01 | 2005-12-01 |
| COSTA, Andrea Frances | Director | 2014-12-11 | 2018-07-05 |
| EHREN, Stijn Michiel | Director | 2008-12-05 | 2011-12-13 |
| HALLAS, David Charles | Director | 2008-12-05 | 2012-09-25 |
| HARBERG JR., Allen | Director | 2013-01-31 | 2019-06-03 |
| HILADO, Maria Teresa | Director | 2008-12-05 | 2009-07-02 |
| KALFF, Tjeerd | Director | — | 1994-04-30 |
| KOEHLER, Steven Hubrig | Director | 2008-12-05 | 2011-07-22 |
| LANZ CANDURIN, Helene Tatiana | Director | 2024-08-01 | 2026-01-31 |
| MCCOY JR., Barry Lee | Director | 2019-06-03 | 2023-10-31 |
| MCDOWELL, Mark Andrew Charles | Director | 2011-12-13 | 2012-05-25 |
| MEISLOCH, Karsten Clemens | Director | 2012-06-01 | 2014-12-11 |
| MOEHLENBROCK, Jan | Director | 2017-01-24 | 2024-08-01 |
| PRECIOUS, John Frederick | Director | — | 1995-07-03 |
| STOLP, Ruurd | Director | 2002-05-31 | 2008-12-15 |
| STOLP, Ruurd | Director | 2002-05-31 | 2002-05-31 |
| VAN DOMMELEN, Bernadus Henricus Maria | Director | — | 1994-04-30 |
| VARVELLA VICENTE, Mauricio | Director | 2015-10-01 | 2017-01-24 |
| WETTERHAHN, Pieter Paulus | Director | 2005-12-01 | 2008-06-12 |
| WIEDHAUP, Koenraad | Director | 1994-05-01 | 2000-06-15 |
| WILDERBEEK, Antonius Theodorus Maria | Director | 1994-05-01 | 2002-05-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Merck & Co., Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 211 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-07 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-05 | AA | accounts | Accounts with accounts type full | |
| 2025-09-05 | AAMD | accounts | Accounts amended with accounts type full | |
| 2025-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-30 | AA | accounts | Accounts with accounts type full | |
| 2023-05-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-01 | AA | accounts | Accounts with accounts type full | |
| 2022-06-09 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-05-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-01-26 | AA | accounts | Accounts with accounts type full | |
| 2022-01-17 | SH01 | capital | Capital allotment shares | |
| 2021-05-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-01-28 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+6.8%
£185,890,000 £198,456,000
-
Cash
—
Not reported
-
Net assets
-4.4%
£166,795,000 £159,459,000
-
Employees
-2.7%
259 252
-
Operating profit
+21.7%
£3,944,000 £4,798,000
-
Profit before tax
+3.6%
£7,330,000 £7,596,000
-
Wages
+3.7%
£17,194,000 £17,823,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers